Skip to main content
. 2022 Jan 25;11:e73325. doi: 10.7554/eLife.73325

Table 3. Predictive capability of hypertrophic cardiomyopathy (HCM) virtual-heart technology.

Sensitivity Specificity PPV NPV Accuracy
ACCF/AHA risk model 46.2 46.2 46.2 46.2 46.2
ESC risk model 53.9 38.5 46.7 45.5 46.2
Virtual-heart technology: LGE-T1 84.6 76.9 78.8 83.3 80.1
Virtual-heart technology: LGE only 69.2 76.9 75.0 71.4 73.1

ACCF = American College of Cardiology Foundation, AHA = American Heart Association, ESC = European Society of Cardiology, LGE = late gadolinium enhancement.